Literature DB >> 21522000

Glycemic control and cardiovascular mortality.

Matthew C Riddle1.   

Abstract

PURPOSE OF REVIEW: Diabetes mellitus is associated with several-fold increased risk of cardiovascular events, including death, yet whether treatment of hyperglycemia can reduce this risk remains controversial. RECENT
FINDINGS: Epidemiologic associations between hyperglycemia and cardiovascular risk have been confirmed and extended to levels below those diagnostic of diabetes. Long-term follow-up of treatment early in diabetes suggests benefits may lag 10 years or more after initiation of treatment. Intensive glycemic treatment of high-risk persons with current methods may increase short-term mortality.
SUMMARY: Further analyses of existing data to define high-risk and lower-risk subgroups of patients may allow revision of treatment guidelines. Future studies may begin early in diabetes, require long-term follow-up, and use improved methods of treatment.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21522000     DOI: 10.1097/MED.0b013e3283446b7e

Source DB:  PubMed          Journal:  Curr Opin Endocrinol Diabetes Obes        ISSN: 1752-296X            Impact factor:   3.243


  7 in total

1.  Functional differences between healthy and diabetic endothelial cells on topographical cues.

Authors:  Marie F A Cutiongco; Bryan M X Chua; Dawn J H Neo; Muhammad Rizwan; Evelyn K F Yim
Journal:  Biomaterials       Date:  2017-10-25       Impact factor: 12.479

Review 2.  Evolving understanding of cardiovascular protection by SGLT2 inhibitors: focus on renal protection, myocardial effects, uric acid, and magnesium balance.

Authors:  Evan C Ray
Journal:  Curr Opin Pharmacol       Date:  2020-07-15       Impact factor: 5.547

Review 3.  Hypoglycemia as a driver of cardiovascular risk in diabetes.

Authors:  Amir Moheet; Elizabeth R Seaquist
Journal:  Curr Atheroscler Rep       Date:  2013-09       Impact factor: 5.113

Review 4.  Diabetes, Endothelial Dysfunction, and Vascular Repair: What Should a Diabetologist Keep His Eye on?

Authors:  V Altabas
Journal:  Int J Endocrinol       Date:  2015-05-18       Impact factor: 3.257

5.  GATA4 protects against hyperglycemia‑induced endothelial dysfunction by regulating NOX4 transcription.

Authors:  Hongfei Xu; Zhen Wang; Zewei Sun; Yiming Ni; Liangrong Zheng
Journal:  Mol Med Rep       Date:  2017-11-14       Impact factor: 2.952

6.  Long-term follow-up of a hospital-based, multi-intervention programme in type 2 diabetes mellitus: impact on cardiovascular events and death.

Authors:  Anne Pernille Ofstad; Geir Reinvik Ulimoen; Elsa Orvik; Kåre Inge Birkeland; Lars L Gullestad; Morten Wang Fagerland; Odd Erik Johansen
Journal:  J Int Med Res       Date:  2017-06-19       Impact factor: 1.671

7.  The association of body mass index with the risk of type 2 diabetes: a case-control study nested in an electronic health records system in the United States.

Authors:  Michael L Ganz; Neil Wintfeld; Qian Li; Veronica Alas; Jakob Langer; Mette Hammer
Journal:  Diabetol Metab Syndr       Date:  2014-04-03       Impact factor: 3.320

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.